Shaowei Wu1,2, Eunyoung Cho3,4,5, Wen-Qing Li3,4, Abrar A Qureshi3,4,5,6. 1. Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, Beijing, China. 2. Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA, USA. 3. Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, USA. 4. Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA. 5. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 6. Department of Dermatology, Rhode Island Hospital, Providence, RI, USA.
Abstract
Background: The association between history of keratinocyte carcinoma (KC, also known as nonmelanoma skin cancer) and risk of developing invasive melanoma has not been assessed comprehensively using prospective data. Methods: We followed 91 846 women in the Nurses' Health Study (NHS; 1984-2010), 114 918 women in the NHSII (1989-2011), and 48 946 men in the Health Professionals Follow-up Study (1986-2010) for diagnoses of KC and melanoma biennially. Cox proportional hazards models were used to compute hazard ratios (HRs) and 95% confidence intervals (CIs) of melanoma associated with history of KC, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC). All statistical tests were two-sided. Results: We documented 1949 melanomas, 38 842 BCCs, and 7462 SCCs over 6.4 million person-years of follow-up. After adjustment for other risk factors, a personal history of KC was associated with an increased risk of melanoma (meta-analysis HR = 2.22, 95% CI = 1.73 to 2.85). The association was more apparent among participants with a history of both BCC and SCC (HR = 3.40, 95% CI = 1.60 to 7.19) than among participants with a history of BCC only (HR = 2.20, 95% CI = 1.80 to 2.70) or SCC only (HR = 1.56, 95% CI = 0.98 to 2.46), and there was a strong risk-increasing trend associated with a higher number of reported KCs removed by surgery ( P trend < .001). In women, KC history was more strongly associated with head/neck melanomas (HR = 4.17, 95% CI = 2.77 to 6.27) than with trunk or limb melanomas (both HRs < 2.50, P heterogeneity = .04). Conclusions: Our results provide novel insights for the relationship between KC history and risk of developing melanoma, which may be important for melanoma prevention.
Background: The association between history of keratinocyte carcinoma (KC, also known as nonmelanoma skin cancer) and risk of developing invasive melanoma has not been assessed comprehensively using prospective data. Methods: We followed 91 846 women in the Nurses' Health Study (NHS; 1984-2010), 114 918 women in the NHSII (1989-2011), and 48 946 men in the Health Professionals Follow-up Study (1986-2010) for diagnoses of KC and melanoma biennially. Cox proportional hazards models were used to compute hazard ratios (HRs) and 95% confidence intervals (CIs) of melanoma associated with history of KC, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC). All statistical tests were two-sided. Results: We documented 1949 melanomas, 38 842 BCCs, and 7462 SCCs over 6.4 million person-years of follow-up. After adjustment for other risk factors, a personal history of KC was associated with an increased risk of melanoma (meta-analysis HR = 2.22, 95% CI = 1.73 to 2.85). The association was more apparent among participants with a history of both BCC and SCC (HR = 3.40, 95% CI = 1.60 to 7.19) than among participants with a history of BCC only (HR = 2.20, 95% CI = 1.80 to 2.70) or SCC only (HR = 1.56, 95% CI = 0.98 to 2.46), and there was a strong risk-increasing trend associated with a higher number of reported KCs removed by surgery ( P trend < .001). In women, KC history was more strongly associated with head/neck melanomas (HR = 4.17, 95% CI = 2.77 to 6.27) than with trunk or limb melanomas (both HRs < 2.50, P heterogeneity = .04). Conclusions: Our results provide novel insights for the relationship between KC history and risk of developing melanoma, which may be important for melanoma prevention.
Authors: Carol A Rosenberg; Janardan Khandekar; Philip Greenland; Rebecca J Rodabough; Anne McTiernan Journal: Cancer Date: 2006-02-01 Impact factor: 6.860
Authors: David C Whiteman; Mark Stickley; Peter Watt; Maria Celia Hughes; Marcia B Davis; Adèle C Green Journal: J Clin Oncol Date: 2006-07-01 Impact factor: 44.544
Authors: R M van Dam; Z Huang; E Giovannucci; E B Rimm; D J Hunter; G A Colditz; M J Stampfer; W C Willett Journal: Am J Clin Nutr Date: 2000-01 Impact factor: 7.045
Authors: Erikka Loftfield; Neal D Freedman; Barry I Graubard; Albert R Hollenbeck; Fatma M Shebl; Susan T Mayne; Rashmi Sinha Journal: J Natl Cancer Inst Date: 2015-01-20 Impact factor: 13.506
Authors: Alan C Geller; Richard W Clapp; Arthur J Sober; Lou Gonsalves; Lloyd Mueller; Cindy L Christiansen; Waqas Shaikh; Donald R Miller Journal: J Clin Oncol Date: 2013-09-16 Impact factor: 44.544
Authors: Catherine M Olsen; Michael S Zens; Therese A Stukel; Carlotta Sacerdote; Yu-Mei Chang; Bruce K Armstrong; Veronique Bataille; Marianne Berwick; J Mark Elwood; Elizabeth A Holly; Connie Kirkpatrick; Thomas Mack; Julia Newton Bishop; Anne Østerlind; Anthony J Swerdlow; Roberto Zanetti; Adèle C Green; Margaret R Karagas; David C Whiteman Journal: Int J Cancer Date: 2009-02-15 Impact factor: 7.396
Authors: Marina Kvaskoff; Nirmala Pandeya; Adèle C Green; Susan Perry; Catherine Baxter; Marcia B Davis; Rohan Mortimore; Lorraine Westacott; Dominic Wood; Joe Triscott; Richard Williamson; David C Whiteman Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-10-01 Impact factor: 4.254
Authors: Fengju Song; Abrar A Qureshi; Edward L Giovannucci; Charlie S Fuchs; Wendy Y Chen; Meir J Stampfer; Jiali Han Journal: PLoS Med Date: 2013-04-23 Impact factor: 11.069
Authors: Hyunje G Cho; Karen Y Kuo; Shufeng Li; Irene Bailey; Sumaira Aasi; Anne Lynn S Chang; Anthony E Oro; Jean Y Tang; Kavita Y Sarin Journal: JCI Insight Date: 2018-08-09
Authors: Niina Korhonen; Leea Ylitalo; Tiina Luukkaala; Julius Itkonen; Henni Häihälä; Juha Jernman; Erna Snellman; Johanna Palve Journal: Arch Dermatol Res Date: 2020-08-09 Impact factor: 3.017